Life Science REIT PLC (LABS)

Category Property - Direct UK

Sell

33.10p

Buy

33.40p

arrow-up0.10p (+0.30%)

Discount/Premium

-59.39%

Estimated NAV

81.26p

Prices updated at 26 Jul 2024, 16:35 BST

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.

FTSE All-Share

1.35%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

	33.00
Launch date	19 Nov 2021
	33.40p - 32.80p
	76.80p - 32.70p
	81.10 as of 31 Dec 2023
Ongoing charge audited (%)	1.7
	1.79
	0.00
	2.53
	437,719.43
	350.00m
	115.85m
	130.84
	Semi-Annually
	£393.11m
	£276.15m
	-50.75
	-38.77
	-
Fund comparative index	No benchmark
	SA
	0.96m
	0.47m
	GB00BP5X4Q29

Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.